维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

18篇 您的检索式：作者名="Borstnar"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	High levels of uPA and PAI-1 predict a good response to anthracyclines显示文摘	Borstnar S Sadikov A Mozina B		Breast Cancer Res Treat0，121，3：	1
	2	Prognostic and predictive value of the urokinase-type plasminogen activator and its inhibitors PAI-1 and PAI-2 in operable breast cancer显示文摘	Cufer T Borstnar S Vrhovec I	2003	Int-J-Biol-Markers2003，18，2：	1
	3	Pneumocystis Jirovecii Pneumonia in Renal Transplant Recipients: A National Center Experience显示文摘	S. Borstnar J. Lindic J. Tomazic A. Kandus A. Pikelj J. Prah M. Skvarc U. Godnov D. Kovac	2013	Transplantation Proceedings2013，，4：	1
	4	Pneumocystis jirovecii pneumonia in renal transplant recipients:a national center experience显示文摘	Borstnar S Lindic J Tomazic J	2013	Transplant Proc2013，45，4：	1
	5	Pneumocystis jirovecii pneumonia in renal transplant recipients:a national center experience显示文摘	Borstnar S Lindic J Tomazic J	2013	Transplant Proc2013，45，4：	1
	6	High levels of uPA and PA1-1predict a good response to anthracyclines 显示文摘	Borstnar S Sadikov A Mozina B	2010	Breast Cancer ResTreat2010，121，61：	1
	7	Prognostic value of the urokinase-type plasminogen activator,and its inhibitors and receptor in breast cancer patients显示文摘	Borstnar S Vrhovec I Svetic B	2002	Clin Breast Cancer2002，3，2：	1
	8	Prognostic and predictive value of cathepsins D and L in operable breast cancer patients 显示文摘	Vrhovec I Borstnar S	2005	Neoplasma2005，52，1：	1
	9	Prognostic and predictive value of the urokinse-type plasminogen activator (uPA) and its inhibitors PAI-1 and PAI-2 in operable breast cancer显示文摘	Curer T Borstnar S Vrhovec J	2003	Int J Biol Markers2003，18，2：	1
	10	Prognostic and predictive value of the urokinase - type plasminogen activator (uPA) and its inhibitors PAI- 1 and PAI-2 in operable breast cancer显示文摘	Cufer T Borstnar S Vrhovec I	2003	Int J Biol Markers2003，18，2：	1
	11	Prognostic and predictive value of cathepsins D and L in operable breast cancer patients显示文摘	Jagodic M Vrhovec I Borstnar S	2005	Neoplasma2005，52，1：	1
	12	Prognostic and predictive value of cathepsins D and L in operable breast cancer patients显示文摘	JAGODIC M VRHOVEC I BORSTNAR S	2005	Neoplasma2005，52，1：	1
	13	Prognostic value of the urokinase-type plasminogen activator, and its inhibitors and receptor in breast cancer patients显示文摘	Vrhovec I Svetic B	2002	Clin Breast Cancer2002，3，2：	1
	14	Prognostic and predictive value of cathepsins D and L in operable breast cancer patients显示文摘	Jagodic M Vrhovec I Borstnar S	2005	Neoplasma2005，129，17：	1
	15	Prognostic and predictive value of the urokinase-type plasminogen activator (uPA) and its inhibitors PAI-1 and PAI-2 in operable breast cancer显示文摘	CUFER T BORSTNAR S VRHOVEC I	2003	Int J Biol Markers2003，18，2：	1
	16	Prognostic and predictive value of the urokinase-type plasminogen activator(UPA) and its inhibitors PAI-1 and PAI-2 in operable breast cancer显示文摘	Cufer T Borstnar S Vrhovec J	2003	Int J Biol Markers2003，18，2：	1
	17	Combination therapy of lapatinib and capecitabine for ErbB2-positive metastatic or locally advanced breast cancer:results from the Lapatinib Expanded Access Program(LEAP) in Central and Eastern Europe显示文摘	Greil R Borstnar S Petráková K	2011	Onkologie2011，34，5：	1
	18	Prognostic and predictive value of the urokinase- type plasminogen activator (uPA) and its inhibitors PAI- 1 and PAI - 2 inoperable breast cancer 显示文摘	Cufer T Borstnar S Vrhovec I	2003	Int J Biol Marders2003，18，2：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费